Wed, August 30, 2023
Tue, August 29, 2023
Mon, August 28, 2023

Rick Bienkowski Reiterated (BEAM) at Buy and Held Target at $56 on, Aug 29th, 2023

Rick Bienkowski of Cantor Fitzgerald, Reiterated "Beam Therapeutics Inc." (BEAM) at Buy and Held Target at $56 on, Aug 29th, 2023.

Rick has made no other calls on BEAM in the last 4 months.



There are 4 other peers that have a rating on BEAM. Out of the 4 peers that are also analyzing BEAM, 3 agree with Rick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Decreased Target to $35 on, Wednesday, August 9th, 2023
  • Richard Law of "Credit Suisse" Maintained at Hold with Increased Target to $47 on, Wednesday, August 9th, 2023
  • Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $42 on, Thursday, May 11th, 2023


This is the rating of the analyst that currently disagrees with Rick


  • Samantha Semenkow of "Citigroup" Maintained at Strong Buy with Decreased Target to $56 on, Wednesday, August 9th, 2023